TY - JOUR
T1 - Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome
T2 - An international multicenter survey
AU - The Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
AU - The European Society for Clinical Nutrition and Metabolism
AU - Pironi, Loris
AU - Steiger, Ezra
AU - Joly, Francisca
AU - Jeppesen, Palle B.
AU - Wanten, Geert
AU - Sasdelli, Anna S.
AU - Chambrier, Cecile
AU - Aimasso, Umberto
AU - Mundi, Manpreet S.
AU - Szczepanek, Kinga
AU - Jukes, Amelia
AU - Theilla, Miriam
AU - Kunecki, Marek
AU - Daniels, Joanne
AU - Serlie, Mireille
AU - Poullenot, Florian
AU - Cooper, Sheldon C.
AU - Rasmussen, Henrik H.
AU - Compher, Charlene
AU - Seguy, David
AU - Crivelli, Adriana
AU - Santarpia, Lidia
AU - Guglielmi, Francesco W.
AU - Kozjek, Nada Rotovnik
AU - Schneider, Stéphane M.
AU - Ellegard, Lars
AU - Thibault, Ronan
AU - Matras, Przemysław
AU - Matysiak, Konrad
AU - Van Gossum, Andrè
AU - Forbes, Alastair
AU - Wyer, Nicola
AU - Taus, Marina
AU - Virgili, Nuria M.
AU - O'Callaghan, Margie
AU - Chapman, Brooke
AU - Osland, Emma
AU - Cuerda, Cristina
AU - Udvarhelyi, Gábor
AU - Jones, Lynn
AU - Won Lee, Andre D.
AU - Masconale, Luisa
AU - Orlandoni, Paolo
AU - Spaggiari, Corrado
AU - Díez, Marta Bueno
AU - Doitchinova-Simeonova, Maryana
AU - Serralde-Zúñiga, Aurora E.
AU - Olveira, Gabriel
AU - Krznaric, Zeljko
AU - Czako, Laszlo
N1 - Publisher Copyright:
© 2021 European Society for Clinical Nutrition and Metabolism
PY - 2021/10/1
Y1 - 2021/10/1
N2 - Background and aims: The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries. Methods: The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1–2, 2–3 and >3 L/day. Results: In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn’ disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland. Conclusions: SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.
AB - Background and aims: The case-mix of patients with intestinal failure due to short bowel syndrome (SBS-IF) can differ among centres and may also be affected by the timeframe of data collection. Therefore, the ESPEN international multicenter cross-sectional survey was analyzed to compare the characteristics of SBS-IF cohorts collected within the same timeframe in different countries. Methods: The study included 1880 adult SBS-IF patients collected in 2015 by 65 centres from 22 countries. The demographic, nutritional, SBS type (end jejunostomy, SBS-J; jejuno-colic anastomosis, SBS-JC; jejunoileal anastomosis with an intact colon and ileocecal valve, SBS-JIC), underlying disease and intravenous supplementation (IVS) characteristics were analyzed. IVS was classified as fluid and electrolyte alone (FE) or parenteral nutrition admixture (PN). The mean daily IVS volume, calculated on a weekly basis, was categorized as <1, 1–2, 2–3 and >3 L/day. Results: In the entire group: 60.7% were females and SBS-J comprised 60% of cases, while mesenteric ischaemia (MI) and Crohn’ disease (CD) were the main underlying diseases. IVS dependency was longer than 3 years in around 50% of cases; IVS was infused ≥5 days/week in 75% and FE in 10% of cases. Within the SBS-IF cohort: CD was twice and thrice more frequent in SBS-J than SBS-JC and SBS-JIC, respectively, while MI was more frequent in SBS-JC and SBS-JIC. Within countries: SBS-J represented 75% or more of patients in UK and Denmark and 50-60% in the other countries, except Poland where SBS-JC prevailed. CD was the main underlying disease in UK, USA, Denmark and The Netherlands, while MI prevailed in France, Italy and Poland. Conclusions: SBS-IF type is primarily determined by the underlying disease, with significant variation between countries. These novel data will be useful for planning and managing both clinical activity and research studies on SBS.
KW - Epidemiology
KW - Home parenteral nutrition
KW - Intestinal failure
KW - Intravenous supplementation
KW - Short bowel syndrome
UR - http://www.scopus.com/inward/record.url?scp=85113146967&partnerID=8YFLogxK
U2 - 10.1016/j.clnesp.2021.07.004
DO - 10.1016/j.clnesp.2021.07.004
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34620351
AN - SCOPUS:85113146967
SN - 2405-4577
VL - 45
SP - 433
EP - 441
JO - Clinical Nutrition ESPEN
JF - Clinical Nutrition ESPEN
ER -